Sanofi Increase Decrease In Cash And Cash Equivalents
Sanofi (SNYNF) reported Increase Decrease In Cash And Cash Equivalents of EUR 216.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2026-02-17
| Period end | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|
| 2025-12-31 | 216.00M EUR 20-F · filed 2026-02-17 | |
| 2025-06-30 | 7.92B EUR 6-K · filed 2025-10-27 | |
| 2024-12-31 | -1.27B EUR 20-F · filed 2026-02-17 | |
| 2024-06-30 | -1.92B EUR 6-K · filed 2025-10-27 | |
| 2023-12-31 | -4.03B EUR 20-F · filed 2026-02-17 | |
| 2023-06-30 | -4.74B EUR 6-K · filed 2024-07-25 | |
| 2022-12-31 | 2.64B EUR 20-F · filed 2025-02-13 | |
| 2022-06-30 | -3.20B EUR 6-K · filed 2023-07-28 | |
| 2021-12-31 | -3.82B EUR 20-F · filed 2024-02-23 | |
| 2021-06-30 | -4.19B EUR 6-K · filed 2022-07-28 | |
| 2020-12-31 | 4.49B EUR 20-F · filed 2023-02-24 | |
| 2020-06-30 | 6.54B EUR 6-K · filed 2021-07-29 | |
| 2019-12-31 | 2.50B EUR 20-F · filed 2022-02-23 | |
| 2019-06-30 | -183.00M EUR 6-K · filed 2020-07-29 | |
| 2018-12-31 | -3.39B EUR 20-F · filed 2021-03-04 | |
| 2017-12-31 | 42.00M EUR 20-F · filed 2020-03-05 | |
| 2016-12-31 | 1.13B EUR 20-F · filed 2019-03-08 | |
| 2015-12-31 | 1.81B EUR 20-F/A · filed 2018-03-16 |